1. Home
  2. AEG vs BMRN Comparison

AEG vs BMRN Comparison

Compare AEG & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aegon Ltd. New York Registry Shares

AEG

Aegon Ltd. New York Registry Shares

N/A

Current Price

$8.62

Market Cap

12.1B

Sector

Finance

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$57.23

Market Cap

12.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEG
BMRN
Founded
1983
1996
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
12.3B
IPO Year
1997
1999

Fundamental Metrics

Financial Performance
Metric
AEG
BMRN
Price
$8.62
$57.23
Analyst Decision
Hold
Buy
Analyst Count
2
28
Target Price
$9.88
★ $90.78
AVG Volume (30 Days)
★ 5.4M
2.4M
Earning Date
02-09-2023
11-02-2026
Dividend Yield
★ 4.80%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.14
Revenue
N/A
★ $1,313,646,000.00
Revenue This Year
N/A
$20.05
Revenue Next Year
$1.99
$14.91
P/E Ratio
★ $7.91
$405.29
Revenue Growth
N/A
★ 17.62
52 Week Low
$6.75
$49.26
52 Week High
$9.64
$70.98

Technical Indicators

Market Signals
Indicator
AEG
BMRN
Relative Strength Index (RSI) 56.25 50.38
Support Level $8.34 $53.19
Resistance Level $8.75 $58.39
Average True Range (ATR) 0.10 1.82
MACD 0.06 0.31
Stochastic Oscillator 86.73 70.56

Price Performance

Historical Comparison
AEG
BMRN

About AEG Aegon Ltd. New York Registry Shares

Aegon is a life insurance and long-term savings business listed in the Netherlands. It was listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, the United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. In recent years, Aegon has been moving through an extensive transformation program during which management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the company that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile earnings products and recycle capital into capital-light and more predictable strategic businesses.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: